Cloning and Germline Intervention: U.S. Perspectives
By Marcy Darnovsky
| 10. 13. 2003
Perspectives on Reproductive Technologies and Biomedicine
Presentation at The Within and Beyond Human Nature conference, Berlin, Germany
Unlike selective abortion and PGD, the reproductive genetic
procedures on which I'm going to focus today are not being used
in doctors' offices and fertility clinics. No human child has
been produced by means of germline engineering or reproductive
cloning. But the discussion of these possibilities is well underway
in the United States, and that discussion is itself already
shaping our political values and social futures.
I'm going to try in the next few minutes to give you a quick
overview of how germline engineering (or inheritable genetic
modification) and reproductive cloning are being discussed in
the U.S.
First a very brief description of the mainstream advocacy
in the U.S. of these techniques of inheritable genetic modification-that
is, for the production of "enhanced children," or
what the U.S. media often call "designer babies."
Second, some comments on the challenges of convincing U.S.
progressives and feminists that the adoption of these practices
would pose grave threats to their own commitments to social
justice and equality-and that opposing these procedures...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...